MYRIAD GENETICS, INC. Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss
MYRIAD GENETICS, INC. (MYGN) reported Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss of $0 for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-08.
Financial Statements › Income Statement › Other Income
us-gaap:MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments · last filed 2024-11-08
- MYRIAD GENETICS, INC. marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2024-09-30 was $0.00.
- MYRIAD GENETICS, INC. marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2023-12-31 was $0.00.
- MYRIAD GENETICS, INC. marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2023-09-30 was -$100.00K.
- MYRIAD GENETICS, INC. marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2023-06-30 was -$900.00K.
- MYRIAD GENETICS, INC. marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for fiscal 2023 was -$1.50M.
- MYRIAD GENETICS, INC. marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for fiscal 2022 was $0.00.
- MYRIAD GENETICS, INC. marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for fiscal 2021 was $0.00.
| Period end | Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss 3 month | Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss 6 month | Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss 9 month | Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss 12 month |
|---|---|---|---|---|
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $0.00 10-Q · filed 2024-11-08 | ||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-07 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$100.00K derived: sum of 2 quarters · filed 2024-11-08 | -$1.00M derived: sum of 3 quarters · filed 2024-11-08 | -$1.50M 10-K · filed 2024-02-28 |
| 2023-09-30 | -$100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$1.00M derived: sum of 2 quarters · filed 2024-11-08 | -$1.50M 10-Q · filed 2024-11-08 | -$1.50M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | -$900.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$1.40M 10-Q · filed 2024-08-07 | -$1.40M derived: sum of 3 quarters · filed 2024-08-07 | -$1.40M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | -$500.00K 10-Q · filed 2023-05-04 | -$500.00K derived: sum of 2 quarters · filed 2024-02-28 | -$500.00K derived: sum of 3 quarters · filed 2024-02-28 | -$500.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $0.00 derived: sum of 2 quarters · filed 2024-02-28 | $0.00 derived: sum of 3 quarters · filed 2024-02-28 | $0.00 10-K · filed 2024-02-28 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | $0.00 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $0.00 10-Q · filed 2023-08-04 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-04 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |